IL17A and chronic obstructive pulmonary disease: These ectopic lymphoid structures function as “chronic inflammation factories” in COPD, where the IL-17/RANKL-CXCL13 axis perpetuates pathological B cell/T cell/dendritic cell activation, driving persistent inflammation, accelerated tissue damage, and disease progression.74